UF researcher receives grant to study gene involved in pediatric cancers
The study will research detrimental mutations in the human SRP54 gene.
The study will research detrimental mutations in the human SRP54 gene.
The study involves describing the discovery of a novel small molecule, biisoquinolinederivative (DH20931).
The study will evaluate the potential of AB-free kava against tobacco smoke-induced lung cancer.
The grant will fund a phase I/II clinical trial for malignant pediatric gliomas using 8R-70CAR T cells.
The study will focus on understanding the role of DAXX in triple negative breast cancer.
The new research will focus on making a tumor model to test new immunotherapies.
The research will have ramifications for development of DNA repair capacity assays to assess cancer susceptibility or therapeutic efficacy.
Kiley Graim, Ph.D., and her team will study genomic information from a range of animals to gain insight into the mechanisms of rare human cancers.
Juan Guan, Ph.D., will explore the mechanisms behind the assembly and regulation of non-canonical biomolecular condensates.
With a $2.3 million grant, the team will investigate strategies to treat muscle wasting and weakness caused by pancreatic cancer.